HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hudspeth, D. A. Articles by Van Wylen, D. G. Search for Related Content PubMed PubMed Citation Articles by Hudspeth, D. A. Articles by Van Wylen, D. G.

The Annals of Thoracic Surgery, Vol 58, 719-727, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Pentostatin-augmented interstitial adenosine prevents postcardioplegia injury in damaged hearts

DA Hudspeth, MW Williams, ZQ Zhao, H Sato, K Nakanishi, DS McGee, JW Hammon Jr, J Vinten-Johansen and DG Van Wylen
Department of Cardiothoracic Surgery, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27157-1096.

This study tests the hypothesis that the adenosine deaminase inhibitor pentostatin (2-deoxycoformycin), when given before ischemia or during infusions of blood cardioplegia, augments interstitial adenosine levels and prevents postcardioplegia dysfunction in hearts with antecedent ischemia. Twenty-one anesthetized dogs were placed on cardiopulmonary bypass, and the hearts were made globally ischemic for 30 minutes. Dogs received blood cardioplegia with no pentostatin (BCP group, n = 6), pretreatment pentostatin (0.2 mg/kg) infused 5 minutes before global ischemia (PS-PTx group, n = 7), or pentostatin included only in the blood cardioplegia without pretreatment (PS-BCP group, n = 8). Microdialysate myocardial adenosine levels (an index of interstitial fluid levels) increased only modestly in the BCP group (from 0.55 +/- 0.13 microM to 2.64 +/- 0.50 microM) and the PS-BCP group (from 0.55 +/- 0.18 microM to 1.08 +/- 0.48 microM) during normothermic ischemia, but interstitial adenosine levels were not augmented further during cardioplegic arrest in either group. In contrast, the adenosine level in the PS-PTx group was significantly (p < 0.05) augmented during global ischemia (from 0.50 +/- 0.13 microM to 63.16 +/- 28.08 microM) and cardioplegia infusion (to 15.26 microM +/- 5.61 microM). Relative to baseline, postischemic left ventricular performance (end-systolic pressure-volume relation) was depressed in both the BCP (from 5.5 +/- 1.2 mm Hg/mL to 3.8 +/- 0.4 mm Hg/mL) and PS-BCP groups (from 7.1 +/- 0.9 mm Hg/mL to 3.8 +/- 0.7 mm Hg/mL). In contrast, PS-PTx restored postischemic performance (from 6.2 +/- 0.5 mm Hg/mL to 7.5 +/- 0.9 mm Hg/mL).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J Mand'ak, P Zivny, V Lonsky, V Palicka, D Kakrdova, M Marsikova, P Kunes, and J Kubicek Changes in metabolism and blood flow in peripheral tissue (skeletal muscle) during cardiac surgery with cardiopulmonary bypass: the biochemical microdialysis study Perfusion, January 1, 2004; 19(1): 53 - 63. [Abstract] [PDF]

				J. Peart, G. Paul Matherne, R. J. Cerniway, and J. P. Headrick Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart Cardiovasc Res, October 1, 2001; 52(1): 120 - 129. [Abstract] [Full Text] [PDF]

				S. A Manthei, C. M Reiling, and D. G.L Van Wylen Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition Cardiovasc Res, January 1, 1998; 37(1): 171 - 178. [Abstract] [Full Text] [PDF]

				J. Barankiewicz, A. M. Danks, E. Abushanab, L. Makings, T. Wiemann, R. A. Wallis, P. V. P. Pragnacharyulu, A. Fox, and P. J. Marangos Regulation of Adenosine Concentration and Cytoprotective Effects of Novel Reversible Adenosine Deaminase Inhibitors J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1230 - 1238. [Abstract] [Full Text]

				T. O. Cheng, A. Jovanovic, J. R. Lopez, A. E. Alekseev, W. K. Shen, and A. Terzic Adenosine and K+-Induced Ca2+ Loading Ann. Thorac. Surg., August 1, 1997; 64(2): 588 - 589. [Full Text]

				H. Sato, Z.-Q. Zhao, J. E. Jordan, J. C. Todd, R. D. Riley, C. S. Taft, J. W. Hammon Jr., P. Li, X.-l. Ma, and J. Vinten-Johansen BASAL NITRIC OXIDE EXPRESSES ENDOGENOUS CARDIOPROTECTION DURING REPERFUSION BY INHIBITION OF NEUTROPHIL-MEDIATED DAMAGE AFTER SURGICAL REVASCULARIZATION J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 399 - 409. [Abstract] [Full Text]

				R. D. Lasley and R. M. Mentzer Jr Protective Effects of Adenosine in the Reversibly Injured Heart Ann. Thorac. Surg., September 1, 1995; 60(3): 843 - 846. [Abstract] [Full Text]

				J. Vinten-Johansen, Z.-Q. Zhao, and H. Sato Reduction in Surgical Ischemic-Reperfusion Injury With Adenosine and Nitric Oxide Therapy Ann. Thorac. Surg., September 1, 1995; 60(3): 852 - 857. [Abstract] [Full Text]

				H. Sato, Z.-Q. Zhao, D. S. McGee, M. W. Williams, J. W. Hammon Jr., and J. Vinten-Johansen SUPPLEMENTAL L-ARGININE DURING CARDIOPLEGIC ARREST AND REPERFUSION AVOIDS REGIONAL POSTISCHEMIC INJURY J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 302 - 314. [Abstract] [Full Text]